Aquestive Therapeutics (AQST) Return on Sales Growth (5y) (2022 - 2026)
Aquestive Therapeutics (AQST) Return on Sales Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.63 Bn | 30.69 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn |
| 10 | Aquestive Therapeutics | 457.34 Mn | 457.34 Mn | 13.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 |
| Dec 31, 2025 | 4.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | 2.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 2.00 |
| Mar 31, 2023 | 1.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | -1.00 |
| Jun 30, 2022 | -2.00 |